Koppe, Uwe http://orcid.org/0000-0001-9718-5811
Jansen, Klaus http://orcid.org/0000-0002-4878-9421
Schmidt, Axel Jeremias http://orcid.org/0000-0002-6910-4399
Weber, Christoph http://orcid.org/0009-0004-8743-852X
Schulze, Heike
Kulis-Horn, Robert Kasimir http://orcid.org/0000-0001-5803-8624
Tiemann, Carsten http://orcid.org/0000-0003-0240-1468
Marcus, Ulrich http://orcid.org/0000-0002-3143-2717
Funding for this research was provided by:
Robert Koch-Institut
Article History
Received: 18 April 2024
Accepted: 13 June 2024
First Online: 20 June 2024
Declarations
:
: This study was approved by the ethics commission of the Berlin Chamber of Physicians (Ref: Eth-40/22). Since the tested samples and questionnaire data were anonymous and could not be re-identified, no informed consent for retrospective testing for MPXV was required.
: Not applicable.
: CW has received honoraria from ViiV, MSD and Gilead and was a member of the ViiV Advisory Board for long acting PrEP. The other authors declare no conflicts of interest.